In a mouse model of CaCl2-induced AAA, inhibiting VEGF-A signaling suppressed angiogenesis, in association with reduced MMP activities, ECM degradation, and aneurysm growth [5]. The gene discussed is VEGFA; the disease is triple-A syndrome.